PMVP
Closed
Pmv Pharmaceuticals inc
1.05
-0.01 (-0.94%)
Last Update: 01 Jul 2025 23:09:00
Yesterday: 1.06
Day's Range: 0.9642 - 1.07
Send
sign up or login to leave a comment!
When Written:
4.1
PMV Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that is focused on developing and commercializing small molecule drugs that target p53 mutations in cancer. The company was founded in 2013 and is headquartered in Cranbury, New Jersey. PMV Pharmaceuticals' lead drug candidate, PMV-01, is a first-in-class small molecule that targets p53 mutations in cancer. The company is also developing other small molecule drugs that target other oncogenic drivers. PMV Pharmaceuticals has partnerships with several major pharmaceutical companies, including Bristol Myers Squibb and Roche. The company's mission is to develop innovative cancer therapies that can make a meaningful difference in the lives of patients.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








